Giorgio Valentina, Miele Luca, Principessa Luigi, Ferretti Francesca, Villa Maria Pia, Negro Valentina, Grieco Antonio, Alisi Anna, Nobili Valerio
Hepato-metabolic Disease Unit, Bambino Gesù Children Hospital, Rome, Italy.
Clinical Division of Internal Medicine, Gastroenterology and Liver Unit, Complesso Integrato Columbus Hospital, Catholic University of Rome, Italy; Institute of Internal Medicine, Catholic University of Rome, Italy.
Dig Liver Dis. 2014 Jun;46(6):556-60. doi: 10.1016/j.dld.2014.02.010. Epub 2014 Mar 12.
Increased intestinal permeability seems to play a major role in non-alcoholic liver disease development and progression.
To investigate the prevalence of altered intestinal permeability in children with non-alcoholic fatty liver disease, and to study its potential association with the stage of liver disease.
We performed a case-control study examining intestinal permeability in children using the lactulose-mannitol bowel permeability test.
Overall, 39 consecutive patients (30 males, median age 12 years) and 21 controls (14 males, median age 11.8 years) were included. The lactulose/mannitol ratio resulted impaired in 12/39 patients (31%) and none of the controls. Intestinal permeability was higher in children with non-alcoholic fatty liver disease (lactulose/mannitol ratios: 0.038±0.037 vs. 0.008±0.007, p<0.05). Within the non-alcoholic fatty liver disease group, intestinal permeability was increased in children with steatohepatitis compared to those with steatosis only (0.05±0.04 vs. 0.03 vs. 0.03, p<0.05). Pathological lactulose/mannitol ratio correlated with portal inflammation (p=0.02), fibrosis (p=0.0002), and ballooning of hepatocytes (p=0.003). Blood lipopolysaccharides levels were higher in children with steatohepatitis (2.27±0.68 vs. 2.80±0.35, p<0.05).
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with the severity of the disease.
肠道通透性增加似乎在非酒精性肝病的发生和发展中起主要作用。
调查非酒精性脂肪性肝病患儿肠道通透性改变的患病率,并研究其与肝病阶段的潜在关联。
我们进行了一项病例对照研究,使用乳果糖-甘露醇肠通透性试验检测儿童的肠道通透性。
总体而言,纳入了39例连续患者(30例男性,中位年龄12岁)和21例对照(14例男性,中位年龄11.8岁)。12/39例患者(31%)的乳果糖/甘露醇比值受损,而对照组无一例受损。非酒精性脂肪性肝病患儿的肠道通透性更高(乳果糖/甘露醇比值:0.038±0.037对0.008±0.007,p<0.05)。在非酒精性脂肪性肝病组中,与仅患有脂肪变性的儿童相比,脂肪性肝炎患儿的肠道通透性增加(0.05±0.04对0.03对0.03,p<0.05)。病理性乳果糖/甘露醇比值与门静脉炎症(p=0.02)、纤维化(p=0.0002)和肝细胞气球样变(p=0.003)相关。脂肪性肝炎患儿的血脂多糖水平更高(2.27±0.68对2.80±0.35,p<0.05)。
非酒精性脂肪性肝病患儿的肠道通透性增加,且与疾病严重程度相关。